Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Biocompatibility of cutaneous formulations containing lipid nanoparticles

  • At: 2017 FIP Congress in Stockholm (Sweden)
  • Type: Poster
  • By: SILVA, Ana (., Porto, Portugal)
  • Co-author(s): Ana Silva: UFP Energy, Environment and Health Research Unit (FP-ENAS), Universidade Fernando Pessoa, Porto, Portugal;UCIBIO, ReQuimTe, Laboratory of Pharmaceutical Technology, Faculty of Pharmacy, University of Porto, Porto, Portugal
    Maria Helena Amaral: Laboratory of Pharmaceutical Technology/Centre of Research in Pharmaceutical Sciences, Faculty of Pharmacy, Porto, Portugal
    Filipa Eiras: Laboratory of Pharmaceutical Technology/Centre of Research in Pharmaceutical Sciences, Faculty of Pharmacy, Porto, Portugal
    Sara Cunha: Laboratory of Pharmaceutical Technology/Centre of Research in Pharmaceutical Sciences, Faculty of Pharmacy, Porto, Portugal
    Renata Silva: Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, Porto, Portugal
    Eva Martins: Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, Porto, Portugal
    José Sousa Lobo: Laboratory of Pharmaceutical Technology/Centre of Research in Pharmaceutical Sciences, Faculty of Pharmacy, Porto, Portugal
  • Abstract:

    Backgrounds

    Lipid nanoparticles (e.g. nanostructured lipid carriers, NLC) have been proposed for cosmetic and dermatological application, by means of semisolid formulations with appropriate consistency. Several studies demonstrated that lipid nanoparticles are safe for therapeutic and cosmetic uses, despite concerns about the potential toxicity of..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses